Aggressive unifocal bone Langerhans cell histiocytosis with soft tissue extension both responsive to radiotherapy: a case report

Wilmar Ghuijs, Paul G. Kemps, Marta E. Capala, Robert M. Verdijk, Astrid G.S. van Halteren, Robert J.P. van der Wal, Jan A.M. van Laar

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Langerhans cell histiocytosis (LCH) is a rare haematological neoplasm characterized by the accumulation of CD1a+, CD207/Langerin+ histiocytes within inflammatory lesions. LCH can involve any organ, but osteolytic bone lesions are most often encountered. Unifocal bone lesions may regress spontaneously after a thick needle biopsy has been taken. Case presentation: In this case report, we describe the initial presentation of a single BRAFV600E mutated osteolytic LCH lesion in the left proximal humerus of a 46-year-old previously healthy woman. Despite multiple surgical interventions, she unexpectedly experienced progressive disease manifestation with significant soft tissue extension to the surrounding musculature, subcutis and epidermis. Because the disease manifestation remained loco-regional, radiotherapy (RT) (total dose of 20 Gy in 10 fractions) was initiated. Conclusion: The patient achieved a complete remission without any side effects. This case highlights that RT is a rational and relative mild local treatment option for patients with aggressive LCH affecting the bone and surrounding soft tissue.

Original languageEnglish
Article number137
JournalRadiation Oncology
Volume17
Issue number1
DOIs
Publication statusPublished - Dec 2022

Keywords

  • Bone
  • BRAF
  • Langerhans cell histiocytosis
  • LCH
  • Radiotherapy

Fingerprint

Dive into the research topics of 'Aggressive unifocal bone Langerhans cell histiocytosis with soft tissue extension both responsive to radiotherapy: a case report'. Together they form a unique fingerprint.

Cite this